Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T cells activated by avenin peptides and immuno-dominant hordein peptides
Celiac disease (CD) is a common CD4(+) T cell mediated enteropathy driven by gluten in wheat, rye, and barley. Whilst clinical feeding studies generally support the safety of oats ingestion in CD, the avenin protein from oats can stimulate intestinal gluten-reactive T cells isolated from some CD patients in vitro. Our objective was to establish whether ingestion of oats or other grains toxic in CD stimulate an avenin-specific T cell response in vivo. We fed participants a meal of oats (100 g/day over 3 days) to measure the in vivo polyclonal avenin-specific T cell responses to peptides contained within comprehensive avenin peptide libraries in 73 HLA-DQ2.5(+) CD patients. Grain cross-reactivity was investigated using oral challenge with wheat, barley, and rye. Avenin-specific responses were observed in 6/73 HLA-DQ2.5(+) CD patients (8%), against four closely related peptides. Oral barley challenge efficiently induced cross-reactive avenin/hordein-specific T cells in most CD patients, whereas wheat or rye challenge did not. In vitro, immunogenic avenin peptides were susceptible to digestive endopeptidases and showed weak HLA-DQ2.5 binding stability. Our findings indicate that CD patients possess T cells capable of responding to immuno-dominant hordein epitopes and homologous avenin peptides ex vivo, but the frequency and consistency of these T cells in blood is substantially higher after oral challenge with barley compared to oats. The low rates of T cell activation after a substantial oats challenge (100 g/d) suggests that doses of oats commonly consumed are insufficient to cause clinical relapse, and supports the safety of oats demonstrated in long-term feeding studies..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Journal of autoimmunity - 56(2015), Seite 56-65 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hardy, Melinda Y [VerfasserIn] |
|---|
| Links: |
|---|
| RVK: |
|---|
| doi: |
10.1016/j.jaut.2014.10.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1958068608 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1958068608 | ||
| 003 | DE-627 | ||
| 005 | 20230514111432.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaut.2014.10.003 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1958068608 | ||
| 035 | |a (DE-599)GBVOLC1958068608 | ||
| 035 | |a (PRQ)c1316-13429e31b57c41e665b0da7e17c39c7b120cee04db5752a957204d573f01b13c0 | ||
| 035 | |a (KEY)0169686620150000056000000056ingestionofoatsandbarleyinpatientswithceliacdiseas | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ZDB |
| 084 | |a XA 52099 |q AVZ |2 rvk | ||
| 084 | |a 44.78 |2 bkl | ||
| 100 | 1 | |a Hardy, Melinda Y |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T cells activated by avenin peptides and immuno-dominant hordein peptides |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Celiac disease (CD) is a common CD4(+) T cell mediated enteropathy driven by gluten in wheat, rye, and barley. Whilst clinical feeding studies generally support the safety of oats ingestion in CD, the avenin protein from oats can stimulate intestinal gluten-reactive T cells isolated from some CD patients in vitro. Our objective was to establish whether ingestion of oats or other grains toxic in CD stimulate an avenin-specific T cell response in vivo. We fed participants a meal of oats (100 g/day over 3 days) to measure the in vivo polyclonal avenin-specific T cell responses to peptides contained within comprehensive avenin peptide libraries in 73 HLA-DQ2.5(+) CD patients. Grain cross-reactivity was investigated using oral challenge with wheat, barley, and rye. Avenin-specific responses were observed in 6/73 HLA-DQ2.5(+) CD patients (8%), against four closely related peptides. Oral barley challenge efficiently induced cross-reactive avenin/hordein-specific T cells in most CD patients, whereas wheat or rye challenge did not. In vitro, immunogenic avenin peptides were susceptible to digestive endopeptidases and showed weak HLA-DQ2.5 binding stability. Our findings indicate that CD patients possess T cells capable of responding to immuno-dominant hordein epitopes and homologous avenin peptides ex vivo, but the frequency and consistency of these T cells in blood is substantially higher after oral challenge with barley compared to oats. The low rates of T cell activation after a substantial oats challenge (100 g/d) suggests that doses of oats commonly consumed are insufficient to cause clinical relapse, and supports the safety of oats demonstrated in long-term feeding studies. | ||
| 540 | |a Nutzungsrecht: Copyright © 2014 Elsevier Ltd. All rights reserved. | ||
| 650 | 4 | |a Epitopes, T-Lymphocyte - administration & dosage | |
| 650 | 4 | |a Lymphocyte Activation - immunology | |
| 650 | 4 | |a Peptides - administration & dosage | |
| 650 | 4 | |a Hordeum - chemistry | |
| 650 | 4 | |a Peptides - immunology | |
| 650 | 4 | |a T-Lymphocyte Subsets - immunology | |
| 650 | 4 | |a Avena sativa - chemistry | |
| 650 | 4 | |a Glutens - chemistry | |
| 650 | 4 | |a Celiac Disease - immunology | |
| 650 | 4 | |a Epitopes, T-Lymphocyte - immunology | |
| 650 | 4 | |a Peptides - chemistry | |
| 650 | 4 | |a Prolamins - chemistry | |
| 650 | 4 | |a Epitopes, T-Lymphocyte - chemistry | |
| 650 | 4 | |a Cross Reactions - immunology | |
| 700 | 1 | |a Tye-Din, Jason A |4 oth | |
| 700 | 1 | |a Stewart, Jessica A |4 oth | |
| 700 | 1 | |a Schmitz, Frederike |4 oth | |
| 700 | 1 | |a Dudek, Nadine L |4 oth | |
| 700 | 1 | |a Hanchapola, Iresha |4 oth | |
| 700 | 1 | |a Purcell, Anthony W |4 oth | |
| 700 | 1 | |a Anderson, Robert P |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of autoimmunity |d Amsterdam : Elsevier, 1988 |g 56(2015), Seite 56-65 |w (DE-627)165660295 |w (DE-600)639452-8 |w (DE-576)022914277 |x 0896-8411 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2015 |g pages:56-65 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.jaut.2014.10.003 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25457306 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a XA 52099 |
| 936 | b | k | |a 44.78 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 56 |j 2015 |h 56-65 | ||